The biotech company’s pivot into digital assets marks one of the largest treasury financings to date, underscoring growing institutional demand for tokenized finance.
Menu
The biotech company’s pivot into digital assets marks one of the largest treasury financings to date, underscoring growing institutional demand for tokenized finance.
Ultricies augue id venenatis at egestas aenean semper ac lectus praesent consequat.
